These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15613935)

  • 21. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study.
    Bird H; Broggini M
    J Rheumatol; 2000 Dec; 27(12):2791-7. PubMed ID: 11128665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression.
    Staner L; Kerkhofs M; Detroux D; Leyman S; Linkowski P; Mendlewicz J
    Sleep; 1995 Jul; 18(6):470-7. PubMed ID: 7481419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants and the risk of suicidal behaviors.
    Jick H; Kaye JA; Jick SS
    JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous ecchymoses due to paroxetine administration.
    Cooper TA; Valcour VG; Gibbons RB; O'Brien-Falls K
    Am J Med; 1998 Feb; 104(2):197-8. PubMed ID: 9528740
    [No Abstract]   [Full Text] [Related]  

  • 27. Doxepin and amitriptyline-perphenazine in mixed anxious-depressed neurotic outpatients: a collaborative controlled study.
    Rickels K; Hutchison JC; Weise CC; Csanalosi I; Chung HR; Case WG
    Psychopharmacologia; 1972; 23(4):305-18. PubMed ID: 4554486
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute delirium in amitriptyline-perphenazine therapy of alcoholism.
    Rawson RA; Lipscomb WR; Rozynko J
    Clin Toxicol; 1971 Mar; 4(1):5-10. PubMed ID: 5097485
    [No Abstract]   [Full Text] [Related]  

  • 29. Paroxetine-induced mania.
    Oldroyd J
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):721-2. PubMed ID: 9183122
    [No Abstract]   [Full Text] [Related]  

  • 30. Amitriptyline and perphenazine in depressive illness. A controlled trial.
    Haider I
    Br J Psychiatry; 1967 Feb; 113(495):195-9. PubMed ID: 5340301
    [No Abstract]   [Full Text] [Related]  

  • 31. Serotonin toxicity caused by an interaction between fentanyl and paroxetine.
    Rang ST; Field J; Irving C
    Can J Anaesth; 2008 Aug; 55(8):521-5. PubMed ID: 18676387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine-associated spontaneous sexual stimulation.
    Pae CU; Kim TS; Lee KU; Kim JJ; Lee CU; Lee SJ; Lee C; Paik IH
    Int Clin Psychopharmacol; 2005 Nov; 20(6):339-41. PubMed ID: 16192845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paroxetine-associated psoriasis.
    Osborne SF; Stafford L; Orr KG
    Am J Psychiatry; 2002 Dec; 159(12):2113. PubMed ID: 12450972
    [No Abstract]   [Full Text] [Related]  

  • 34. Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients.
    Geretsegger C; Stuppaeck CH; Mair M; Platz T; Fartacek R; Heim M
    Psychopharmacology (Berl); 1995 Jun; 119(3):277-81. PubMed ID: 7675961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hepatotoxicity with jaundice associated with paroxetine.
    Odeh M; Misselevech I; Boss JH; Oliven A
    Am J Gastroenterol; 2001 Aug; 96(8):2494-6. PubMed ID: 11513198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of paroxetine on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.
    Nemoto K; Mihara K; Nakamura A; Nagai G; Kagawa S; Suzuki T; Kondo T
    Ther Drug Monit; 2012 Apr; 34(2):188-92. PubMed ID: 22377745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report.
    Uguz F; Sonmez EÖ
    Gen Hosp Psychiatry; 2013; 35(3):327.e7-327.e8. PubMed ID: 23312145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin syndrome associated with nefazodone and paroxetine.
    John L; Perreault MM; Tao T; Blew PG
    Ann Emerg Med; 1997 Feb; 29(2):287-9. PubMed ID: 9018197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination of serotonergic agents resulted in severe adverse effects].
    Jägestedt M; von Bahr C
    Lakartidningen; 2004 Apr; 101(18):1618-9. PubMed ID: 15185539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people.
    Draganich LF; Zacny J; Klafta J; Karrison T
    J Gerontol A Biol Sci Med Sci; 2001 Jan; 56(1):M36-41. PubMed ID: 11193231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.